Immix Biopharma

IMMX

Capitalización de mercado USD 739 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
51	51 SEI Investments Oaks, Pennsylvania	USD 694 k	-USD 740 k	-79,792	-54%
52	52 Rafferty Asset Management New York	USD 603 k	+USD 543 k	+58,486	Nuevas
53	53 Barclays London, United Kingdom	USD 547 k	+USD 11.9 k	+1,288	+2%
54	54 RhumbLine Advisers Boston, Massachusetts	USD 525 k	+USD 473 k	+50,944	Nuevas
55	55 Deutsche Bank Frankfurt Am Main Ge, Germany	USD 421 k	+USD 379 k	+40,861	Nuevas
56	56 XTX Topco George Town, Cayman Islands	USD 418 k	-USD 376 k	-40,556	-50%
57	57 Two Sigma Investments New York	USD 414 k	+USD 373 k	+40,181	Nuevas
58	58 Susquehanna International Group Bala Cynwyd, Pennsylvania	USD 399 k	-USD 4.01 M	-432,663	-92%
59	59 Virtus Investment Advisers Hartford, Connecticut	USD 399 k	+USD 359 k	+38,721	Nuevas
60	60 Quadrature Capital London, United Kingdom	USD 388 k	+USD 349 k	+37,637	Nuevas
61	61 Private Advisor Group Morristown, New Jersey	USD 364 k	+USD 5.57 k	+600	+2%
62	62 Certuity North Palm Beach, Florida	USD 361 k	–	–	–
63	63 AllianceBernstein Nashville, Tennessee	USD 358 k	+USD 364 k	+39,290	Nuevas
64	64 Profund Advisors Bethesda, Maryland	USD 302 k	+USD 272 k	+29,305	Nuevas
65	65 Imprint Wealth Mount Pleasant, South Carolina	USD 270 k	-USD 46.5 k	-5,015	-16%
66	66 Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong	USD 265 k	+USD 238 k	+25,629	Nuevas
67	67 MetLife Investment Management Whippany, New Jersey	USD 257 k	+USD 231 k	+24,932	Nuevas
68	68 TritonPoint Partners Chevy Chase, Maryland	USD 253 k	–	–	–
69	69 Concurrent Investment Advisors Tampa, Florida	USD 247 k	-USD 2.33 k	-251	-1%
70	70 Virtu Financial New York	USD 246 k	-USD 225 k	-24,262	-50%
71	71 Invesco Atlanta, Georgia	USD 230 k	+USD 207 k	+22,318	Nuevas
72	72 Vanguard Global Advisers Malvern, Pennsylvania	USD 228 k	+USD 21.8 k	+2,353	+12%
73	73 Quent Capital New York	USD 206 k	+USD 186 k	+20,000	Nuevas
74	74 JP Morgan Chase New York	USD 205 k	+USD 158 k	+17,038	+672%
75	75 GSA Capital Partners London, United Kingdom	USD 205 k	+USD 19.1 k	+2,056	+12%

Immix Biopharma IMMX Capitalización de mercado USD 739 M

Immix Biopharma

IMMX

Capitalización de mercado USD 739 M